Education
About Us
Working with TipRanks
Follow Us
Masimo Corp (MASI)
NASDAQ:MASI
MASI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$107.98 - $194.88
Previous CloseN/A
Volume102.94K
Average Volume (3M)764.44K
Market Cap
$7.78B
Enterprise Value$9.71B
Total Cash (Recent Filing)$149.60M
Total Debt (Recent Filing)$642.20M
Price to Earnings (P/E)116.7
Beta1.01
Next Earnings
Nov 11, 2025EPS Estimate
1.2Last Dividend Ex-Date
Nov 23, 2012Dividend YieldN/A
Share Statistics
EPS (TTM)1.33
Shares Outstanding54,324,814
10 Day Avg. Volume672,967
30 Day Avg. Volume764,440
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.25
Enterprise Value/Revenue5.25
Enterprise Value/Gross Profit9.95
Enterprise Value/Ebitda-82.97
Forecast
1Y Price Target
$188.83Price Target Upside33.97% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Bulls Say, Bears Say
Bulls Say
Financial PerformanceMASI's 2Q25 revenue and EPS beat consensus.
Operational StrategyManagement raised its revenue guidance slightly and raised its EPS guidance to account for a lower tariff impact combined with mitigation efforts.
Product And InnovationMASI is focused on taking share in growth markets, refreshing its installed base with next-gen technology, and bringing AI capabilities to its sensors.
Bears Say
Cost ManagementTariffs will result in a significant headwind to cost of goods sold.
Legal ChallengesMasimo's patent infringement complaint against Apple in the Central District of California is set to begin a jury trial on November 4, 2025.
Operational RisksCertain manufacturing facilities have been operating at less than normal levels due to a cyber attack on MASI's network.
Masimo News
MASI FAQ
What was Masimo Corp’s price range in the past 12 months?
Masimo Corp lowest stock price was $107.98 and its highest was $194.88 in the past 12 months.
What is Masimo Corp’s market cap?
Masimo Corp’s market cap is $7.78B.
When is Masimo Corp’s upcoming earnings report date?
Masimo Corp’s upcoming earnings report date is Nov 11, 2025 which is in 74 days.
How were Masimo Corp’s earnings last quarter?
Masimo Corp released its earnings results on Aug 05, 2025. The company reported $1.33 earnings per share for the quarter, beating the consensus estimate of $1.223 by $0.107.
Is Masimo Corp overvalued?
According to Wall Street analysts Masimo Corp’s price is currently Undervalued.
Does Masimo Corp pay dividends?
Masimo Corp pays a Notavailable dividend of $1 which represents an annual dividend yield of N/A. See more information on Masimo Corp dividends here
What is Masimo Corp’s EPS estimate?
Masimo Corp’s EPS estimate is 1.2.
How many shares outstanding does Masimo Corp have?
Masimo Corp has 54,324,814 shares outstanding.
What happened to Masimo Corp’s price movement after its last earnings report?
Masimo Corp reported an EPS of $1.33 in its last earnings report, beating expectations of $1.223. Following the earnings report the stock price went down -11.734%.
Which hedge fund is a major shareholder of Masimo Corp?
Currently, no hedge funds are holding shares in MASI
Masimo Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$188.83 (33.97% Upside)
$188.83 (33.97% Upside)
Blogger Sentiment
Bullish
MASI Sentiment 75%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 921.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $468.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▲ 0.6%
Last 30 Days ▲ 0.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
21.11%
12-Months-Change
Fundamentals
Return on Equity
-20.54%
Trailing 12-Months
Asset Growth
-16.98%
Trailing 12-Months
Company Description
Masimo Corp
Masimo Corporation (NASDAQ: MASI) is a global medical technology company that specializes in noninvasive monitoring technologies, primarily focusing on the measurement of blood oxygen levels and other vital signs. Founded in 1989, Masimo is known for its innovative products that enhance patient care and improve clinical outcomes across various healthcare settings, including hospitals and home care. The company's core products include its pulse oximetry devices, brain function monitoring systems, and noninvasive hemoglobin measurement technologies, which are widely used in anesthesia, critical care, and emergency medicine.
MASI Company Deck
MASI Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth and significant leadership team expansion, with effective tariff mitigation strategies. However, there were challenges with a decline in capital equipment revenue, cybersecurity expenses, and a decrease in the true incremental metric. Overall, the highlights significantly outweigh the lowlights.View all MASI earnings summariesMASI Stock 12 Month Forecast
Average Price Target
$188.83
▲(33.97% Upside)
Technical Analysis
Ownership Overview
8.88% Insiders
36.14% Mutual Funds
34.18% Other Institutional Investors
0.27% Public Companies and
Individual Investors